MRSH - Educational Analysis * US Equities
Educational Analysis * US Equities

MRSH

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerMRSH
CategoryEducational primer
Last reviewedAugust 9, 2026
You're viewing an older edition of this page.Read the latest edition →

Business profile & competitive position

Marsh & McLennan Companies, Inc. (MRSH) operates in the Financial Services sector, specifically the Insurance – Brokers industry. In that role, the company sits between commercial clients and insurance/reinsurance underwriters, earning commissions and fees for placing risk coverage and providing advisory services rather than bearing underwriting risk itself. That business model produces a different risk profile than a property-casualty insurer. The trailing net margin is 14.2%, and return on equity is 26.5%. An ROE of 26.5% implies the firm is converting its equity base into earnings at an unusually high rate, a profile normally associated with pricing power, repeat client relationships, and operating leverage. The beta is 0.60, meaning the stock has historically moved only about 60% as much as the broader market, consistent with recurring revenue streams and limited covariance with broad market swings. Taken together, the 14.2% net margin and 26.5% ROE suggest MRSH has built durable brokerage economics, even if the dataset does not speak to qualitative claims about brand or market share.

Financial posture

At a market capitalization of $91.5 billion and a trailing P/E of 23.3, MRSH carries a premium multiple relative to many capital-heavy corners of Financial Services. The premium appears to be supported by the profitability metrics: a 14.2% net margin and a 26.5% ROE. The beta of 0.60 gives the stock a defensive tilt—investors should expect lower absolute volatility than the overall market, but also less torque in a broad risk-on rally. Importantly, MRSH is a broker rather than an underwriter, so the high ROE derives from service economics rather than leverage on insurance float or investment gains. That distinction matters when comparing the company to insurance carriers in the same broad sector.

Macro & geopolitical exposure

The Insurance – Brokers classification carries macro exposures that are distinct from underwriting carriers. First, regulation: broker compensation, fiduciary standards, and market-conduct rules can change disclosure burdens or capital costs for risk advisors across multiple jurisdictions. Second, interest rates and credit conditions: insurers’ investment income influences pricing behavior over time, while higher rates can push commercial clients to optimize coverage or retain more risk, altering broker volume. Third, property, catastrophe, and climate risk: severe weather or rising insured losses can shift demand for coverage and reinsurance buying patterns, directly affecting brokerage placement activity. Fourth, currency: because large brokers operate globally, dollar strength or weakness creates translation effects on reported revenue. Trade policy and cross-border supply chains also matter; tariffs or geopolitical tension can raise demand for political-risk, trade-credit, and supply-chain coverage while lowering underlying commercial activity. Finally, cyber risk and digitalization expand the addressable market but also expose the company to operational and reputational risk around client data. None of these are firm-specific forecasts; they are the macro channels inherent to the industry classification.

Recent developments

Institutional filings dominated the recent news flow between late July and early August 2026. On July 25, 2026, Bank of Nova Scotia purchased 110,231 shares, according to defenseworld.net. On July 27, 2026, Gabelli Funds LLC disclosed a new position in the company. Ashton Thomas Securities LLC followed on July 30, 2026, reporting a new position. Finally, on August 1, 2026, Bank of America Corp DE disclosed holdings valued at $856.78 million. Each filing reflects activity as of a prior quarter-end and does not necessarily represent live buying at current prices, but the clustering of institutional ownership disclosures highlights active accumulation by asset managers and banks. At the current price of $191.65, these positions imply a degree of institutional comfort with MRSH’s earnings consistency, though positions alone are not a directional signal.

Earnings behavior & post-earnings drift

MRSH has delivered a clean earnings track record over the last eight reported quarters, beating the consensus every time and producing an average earnings surprise of 3.4%. That 8/8 beat rate suggests the company has reliably managed expectations, though it also raises the possibility that actual business performance has run ahead of the published estimates.

What is notable is what happened after those beats. The average 5-day price move following earnings across the past eight quarters is only 0.45%, classified as “flat” drift. In other words, the headline beats have not reliably translated into sustained near-term momentum. The most recent examples illustrate that pattern clearly. On July 21, 2026, MRSH reported $2.96 versus a $2.88 estimate, a 2.8% positive surprise, yet the stock fell 3.08% the next day before recovering to a 5.84% gain over the following five sessions. On April 16, 2026, the company posted $3.29 versus $3.22, a 2.2% beat, but the stock dropped 3.71% the next day and slid 4.69% over the next five trading days. The January 29, 2026 report delivered the largest surprise of the four at 7.6% ($2.12 vs. $1.97), yet produced essentially no price movement: +0.14% the next day and -0.22% over five days. The October 16, 2025 quarter saw a 3.9% beat ($1.85 vs. $1.78), with the stock rising 1.67% the next day and 0.86% over the next five sessions.

Heading into the next scheduled report on October 15, 2026 (before market open), the consensus EPS estimate is $1.97.

Frequently Asked Questions

What does Marsh & McLennan actually do?

It operates as an insurance broker and professional-services advisor, earning fees and commissions for placing risk coverage and providing consulting services, rather than underwriting insurance policies itself.

How profitable is MRSH?

The most recent data shows a 14.2% net margin and a 26.5% return on equity, supported by a $91.5 billion market capitalization and a P/E multiple of 23.3.

How has MRSH historically reacted to earnings beats?

Over the last eight quarters MRSH beat the consensus 100% of the time with an average surprise of 3.4%, but the average five-day post-earnings price move is just 0.45%, labeled “flat” drift. Recent quarters show that a beat can be followed by either a near-term decline or only modest gains.

For a deeper dive into how institutional analysts rate MRSH, where their estimates cluster, and how the upcoming October 15, 2026 earnings report is positioned, see the full institutional verdict on the platform.

Real Data - Gamma QC Earnings IntelligenceAs of Aug 9, 2026
Marsh & McLennan Companies, Inc. · Financial Services / Insurance - Brokers
$91.5BMarket cap
23.3P/E
14.2%Net margin
26.5%ROE
100%Beat rate, last 8Q
3.4%Avg EPS surprise
0.45%Avg 5-day move after earnings
2026-10-15Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-07-21$2.96$2.88+2.8%-3.08%+5.84%
2026-04-16$3.29$3.22+2.2%-3.71%-4.69%
2026-01-29$2.12$1.97+7.6%+0.14%-0.22%
2025-10-16$1.85$1.78+3.9%+1.67%+0.86%
2025-07-17$2.72$2.67+1.9%--
2025-04-17$3.06$3.02+1.3%--

Previous MRSH editions

Beyond the primer

Get the institutional verdict on MRSH

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the MRSH verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.